ca.nyberg
Submits third-party assay reports on material purchased directly. Based in Poznań.
Section 1
Contribution
Purchases material, pays for assays, and submits the resulting reports to the index.
Records submitted
6
n=6
Annotations
0
n=0
Median purity submitted
99.13%
n=6
Suppliers covered
6
n=6
Section 2
Records submitted
A submitter chose to buy this material and to pay for this assay. That choice is the selection mechanism behind the whole index and it is not random.
| Report | Compound | Supplier | Lot | Lab | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|---|
| AX-2026-041485 | PT-141 (Bremelanotide) | QYB | QYB-2607-L5615 | Medutest | 2026-Q3 | 99.93 | 3.79 | 90.5 | Supplier-supplied | 0 | PASS |
| AX-2025-018921 | Semaglutide | FGP | FGP-2506-J9812 | Janoshik | 2025-Q4 | 99.68 | 4.57 | — | Supplier-supplied | 0 | PASS |
| AX-2025-021108 | Tirzepatide | WXT | WXT-2505-T4814 | PeptideMeter | 2025-Q3 | 97.93 | 3.55 | 98.4 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019678 | Retatrutide | Homopeptide | HOMO-2412-V2760 | Medutest | 2025-Q2 | 97.69 | 4.06 | 94.6 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-020656 | L-Glutathione (reduced) | SSA | SSA-2501-W8087 | Janoshik | 2025-Q1 | 99.36 | 10.93 | 90.8 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019265 | Afamelanotide | TFC | TFC-2502-Y6610 | Janoshik | 2025-Q1 | 98.90 | 4.59 | 104.3 | Supplier-supplied | 0 | PASS |